Design Therapeutics, Inc.

NASDAQ:DSGN

4.96 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -49.588-66.862-63.308-35.533-8.28-2.047
Depreciation & Amortization -5.6020.5370.4060.1290.0050
Deferred Income Tax 000-0.077-0.0710
Stock Based Compensation 13.07213.08810.9254.6890.450
Change In Working Capital 00.7281.9921.396-0.8111.813
Accounts Receivables 000000
Inventory 000000
Accounts Payables -1.219-1.2465.3852.413-0.4130
Other Working Capital 01.974-3.393-1.017-0.3981.813
Other Non Cash Items -0.987-6.051-1.3320.0190.0380.095
Operating Cash Flow -43.105-58.56-51.317-29.377-8.669-0.139
Investing Activities:
Investments In Property Plant And Equipment -0.34-0.256-0.918-1.538-0.0760
Acquisitions Net 000.0390.0520.0330
Purchases Of Investments -230.175-224.703-312.998-86.261-55.5890
Sales Maturities Of Investments 274.47277.49592.8934.15522.1040
Other Investing Activites 000.039-0.052-0.0330
Investing Cash Flow 43.95552.536-220.987-53.644-33.5610
Financing Activities:
Debt Repayment 000044.5310.196
Common Stock Issued 00.7240.662254.2710.0010
Common Stock Repurchased 0.4770.3050.339000
Dividends Paid 000000
Other Financing Activities 0.5130.7240.235124.940.0010
Financing Cash Flow 0.5130.72400.37944.5320.196
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 1.363-5.3-272.069296.192.3020.057
Cash At End Of Period 22.56321.226.5298.5692.3790.077